# FDA Inspection 1046405 - McKesson Corporation dba RxPak - March 22, 2018

Source: https://www.keypedia.com/records/fda_inspections/mckesson-corporation-dba-rxpak/95128efc-57ed-4764-b2ee-a98c44065eae
Source feed: FDA_Inspections

> FDA Inspection 1046405 for McKesson Corporation dba RxPak on March 22, 2018. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1046405
- Company Name: McKesson Corporation dba RxPak
- Inspection Date: 2018-03-22
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 984729 - 2016-07-27](https://www.keypedia.com/records/fda_inspections/mckesson-corporation-dba-rxpak/ff09fd5a-8906-41b6-a175-95f00bbd6460)
- [FDA Inspection 650331 - 2010-03-01](https://www.keypedia.com/records/fda_inspections/mckesson-corporation-dba-rxpak/0e09a648-088a-4e9e-a4e9-0e6dc10899b7)

Company: https://www.keypedia.com/companies/mckesson-corporation-dba-rxpak/d65f7265-a6b2-409b-958a-a69365e81ded

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c